Faraz Ali - Feb 16, 2024 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role
Chief Executive Officer, Director
Signature
/s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
Stock symbol
TNYA
Transactions as of
Feb 16, 2024
Transactions value $
-$37,258
Form type
4
Date filed
2/16/2024, 08:30 PM
Previous filing
Aug 18, 2023
Next filing
Feb 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNYA Common Stock Sale -$37.3K -6.36K -5.32% $5.86 113K Feb 16, 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.
F2 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $5.61 to $6.15. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 Includes 93,750 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.